Antibiotics for ICU patients with sepsis
Part of Infections clinical trials.
This study looks at treating ICU patients with sepsis (a serious body-wide infection) using antibiotics. It may help doctors understand which antibiotic approach works best for critically ill patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were admitted to the general ICU for sepsis or septic shock between January 1, 2020 and December 31, 2020
- Your ICU admission was due to an infection (sepsis/septic shock), not another non-infectious cause
- You were enrolled based on your ICU admission details during that time period
- You should be an adult or child patient only if the hospital’s records include you in this ICU sepsis group (ask the study team if age limits apply)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study monitors how antibiotics behave in the body for ICU patients being treated for sepsis or septic shock. It aims to learn whether better monitoring can support safer, more effective antibiotic use.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This study observes how doctors treat septic shock in intensive care units. It aims to understand current practices and improve care for patients with severe infections and low blood pressure.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
This study looks at different types of sepsis in patients with severe pneumonia. It aims to see how the type of sepsis affects treatment with a common antibiotic called piperacillin/tazobactam.
Hear when a new Septic Patients Admitted to the ICU trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.